Biocorrx Inc (BICX) 0.0277 $BICX
BioCorRx, Inc. Announces New Agreements With Wellness Centers in Slidell, LA, Memphis and Nashville, TN, and Philadelphia, PA
Marketwired - Thu Jan 14, 9:06AM CST
BioCorRx, Inc. (OTCQB: BICX), developer of the BioCorRx(R) Recovery Program, a non-addictive Medication-Assisted Treatment (MAT) program used in the treatment of alcohol and opioid addiction, announces new distribution agreements with existing wellness centers. The agreements are part of the company's continued focus to distribute its addiction treatment program, built around long-lasting Naltrexone therapy, to independent locations nationally. The new centers are to be located in Slidell, LA, Memphis, TN, Nashville, TN, and Philadelphia, PA. Visit www.BeatAddiction.com for the most up to date list of locations treating patients currently or for those coming soon.
BioCorRx, Inc. Announces Agreements With Additional Wellness Centers in California, Wisconsin and Arizona; Recent Appearance on National Television
Marketwired - Mon Dec 07, 2:30PM CST
BioCorRx, Inc. (OTCQB: BICX), developer of the BioCorRx(R) Recovery Program, a Medication-Assisted Treatment (MAT) program used in the treatment of alcohol and opioid addiction, announces new distribution agreements with existing wellness centers. The agreements are part of the company's continued focus to distribute its addiction treatment program, built around long-lasting Naltrexone therapy, to wellness centers nationally. The new centers are to be located in Oxnard, CA, Oconomowoc, WI, and Mesa, AZ. In addition to these recent agreements, many of the centers in other areas previously disclosed are now treating patients. Visit www.BeatAddiction.com for the most up to date list of locations treating patients currently or for those coming soon.
BioCorRx, Inc. Secures Tactical Growth Partners as Strategic Advisors; Announces New Branding Strategy
Marketwired - Wed Nov 18, 6:00AM CST
BioCorRx, Inc. (OTCQB: BICX), developer of the BioCorRx(R) Recovery Program, a Medication-Assisted Treatment (MAT) program, announced today they have entered into an agreement to engage the global business and capital markets advisory firm, Tactical Growth Partners "TGP". The principals of TGP have over seventy-five years of Wall Street experience within the small-cap, emerging growth global market as well as in the fields of medicine, medical technology and business development. TGP will provide assistance with strategic planning and business development, general advisory services, communications to the financial community and other services as agreed to.
BioCorRx, Inc. Announces Agreement with Wellness Center in Atlanta Area; Recent Company Interviews
GlobeNewswire - Thu Oct 08, 7:00AM CDT
BioCorRx, Inc. (OTCQB:BICX), developer of the BioCorRx(R) Recovery Program, a Medication-Assisted Treatment (MAT) program, announces a new distribution agreement with an existing wellness center in the Atlanta area. The agreement is part of the Company's continued focus to distribute its addiction treatment program specific to long-lasting Naltrexone therapy to wellness centers nationally through a partnership with Myriad Medical Marketing (MMM). The new center, Superior Health Care LLC, is run by Dr. Steve Peyroux and is located at 2050 Cumming Way, #100 Canton, GA 30115.
BioCorRx, Inc. Announces New Program and Outlines Growth Strategy in Special Letter to Shareholders
GlobeNewswire - Thu Sep 17, 7:00AM CDT
Dear Fellow Shareholder,
BioCorRx, Inc. Announces Start Fresh Program(r) Agreement with Two Additional Wellness Centers
GlobeNewswire - Thu Sep 03, 7:00AM CDT
BioCorRx, Inc. (BICX), developer of the Start Fresh Program, a Medication-Assisted Treatment (MAT) program, announces distribution agreements to bring the Start Fresh Program into two additional wellness centers. The agreement is part of the company's continued focus to distribute its addiction treatment program to wellness centers nationally through a partnership with Myriad Medical Marketing (MMM). The new centers are Escalon Physical Medicine and Scott Medical Health Center PC. "The upcoming availability of our program at two new centers is exciting as they will be continuing our mission of greater accessibility of the Start Fresh Program throughout the country," stated COO & interim CEO, Brady Granier.
SeeThruEquity Initiates Coverage on BioCorRx Inc. with a Price Target of $0.13
ACCESSWIRE - Wed Jul 22, 8:01AM CDT
NEW YORK, NY / ACCESSWIRE / July 22, 2015 / SeeThruEquity, a leading independent equity research and corporate access firm focused on smallcap and microcap public companies, today announced it has initiated coverage of BioCorRx Inc. (OTCQB: BICX) with a Price Target of $0.13.
BioCorRx, Inc. Chief Financial Officer, Lourdes Felix and Brady Granier, Chief Operating Officer and Interim Chief Executive Officer, Discuss Recent News in a New Audio Interview at SmallCapVoice.com
GlobeNewswire - Mon Jul 20, 7:00AM CDT
SmallCapVoice.com, Inc. (SCV) and BioCorRx, Inc. (OTCQB:BICX) developer of the Start Fresh Program (R) used for the treatment of alcohol and opioid dependence, announced today that a new audio interview is now available. The interview can be heard at http://smallcapvoice.com/blog/7-16-15-smallca...x-inc-bicx
BioCorRx, Inc. Finalizes Asset Purchase Agreement to Acquire Naltrexone Implant Formula for Treating Addiction
GlobeNewswire - Tue Jul 07, 7:00AM CDT
BioCorRx, Inc. (BICX), developer of the Start Fresh Program(R) used for the treatment of alcohol and opioid dependence, announces the finalization of an asset purchase agreement with Trinity Compound Solutions (formerly Trinity Rx Solutions) ("Trinity"
for its Naltrexone implant formula with an option to purchase other formulas from Trinity. The Company had previously entered into a letter of understanding (LOU) with Trinity for this agreement. This naltrexone pellet formula is used by a select compounding pharmacist trained to make the specific implant used in the Start Fresh Program. The Company currently has exclusive use rights to the implant in the U.S. and abroad (excluding Australia and New Zealand).
BioCorRx, Inc. Announces First Patients Treated in Wellness Center Pilot Using the Start Fresh Program
GlobeNewswire - Mon Jul 06, 7:00AM CDT
BioCorRx, Inc. (BICX), developer of the Start Fresh Program, announces update on the Company's pilot program with Myriad Medical Marketing (MMM). The first location in the pilot program, Corona Physical Medicine (CPM), has just treated their first three patients using the Start Fresh Program. CPM is located at 1150 El Camino Avenue, Suite 108, Corona, CA 92879.
BioCorRx, Inc. and Sobriety and Addiction Solutions, LLC Announce Mutual Separation; Plan to Advocate for Wider Naltrexone Implant Use in the Treatment of Addiction
GlobeNewswire - Thu Jul 02, 1:55PM CDT
BioCorRx, Inc. (BICX), developer of the Start Fresh Program, announces the mutual release of Sobriety and Addiction Solutions, LLC (SAS) from its license agreements with the Company. They were previously offering the Start Fresh Program for locations in Walnut Creek, Fresno and Washington D.C. under MyLife Recovery Centers (MyLife). With different views on how to best approach and capture market share of the $35 billion addiction treatment industry, the companies felt that this separation would allow each party to pursue their respective strategies to help more people suffering from addiction in the largely fragmented addiction treatment market.
BUYINS.NET Updates BioCorRx (BICX) SqueezeTrigger Report
M2 - Wed Jun 10, 8:56AM CDT
BUYINS.NET, http://www.buyins.net, a leading provider of Regulation SHO compliance monitoring, short sale trading statistics and market integrity surveillance, has updated coverage on BioCorRx (OTC: BICX) after releasing the latest short sale data through June 9, 2015. The total aggregate number of shares shorted since August 2010 is approximately 55.6 million shares. Approximately 24.95% of daily trading volume is short selling. The SqueezeTrigger price for all BICX shares shorted is $0.22. A short squeeze is expected to begin when shares of BICX close above the $0.22 SqueezeTrigger price.
BioCorRx Inc. Reports First Quarter 2015 Financial Results
GlobeNewswire - Wed May 20, 2:08PM CDT
BioCorRx Inc. Reports First Quarter 2015 Financial Results
BioCorRx, Inc. and Start Fresh Featured on MSNBC, SAMHSA and NIAAA Endorse Medication for Treatment of Alcohol Abuse Disorders
GlobeNewswire - Tue Apr 28, 7:00AM CDT
BioCorRx, Inc. (BICX) announces MSNBC segment featuring Brady Granier, COO and interim CEO, alongside Start Fresh Program and Growing Pains alum, Jeremy Miller. The two were interviewed by Tamron Hall of NewsNation to discuss Jeremy's success with the Start Fresh Program, a medication-assisted treatment program developed by BioCorRx that is used to treat alcohol and opioid addiction. The MSNBC segment originally aired on April 21, 2015 and can be viewed online here.
BioCorRx, Inc. Announces Start Date of Start Fresh Program(r) Pilot at Wellness Center in Corona, CA
GlobeNewswire - Tue Apr 14, 7:00AM CDT
BioCorRx, Inc. (BICX), developer of the Start Fresh Program, announces that the Company's pilot program that was created as a result of an agreement with Myriad Medical Marketing (MMM) is scheduled to launch later this month. As of April 27, 2015 Corona Physical Medicine (CPM) in Corona, CA plans to begin setting appointments with potential patients. CPM is located at 1150 El Camino Avenue, Suite 108, Corona, CA 92879. This will be the first of five planned locations to participate in the Start Fresh pilot program. Upon successful completion of the pilot program, MMM will begin to introduce the Start Fresh Program to other wellness centers nationwide.
BioCorRx, Inc. Reports 2014 Financial Results
GlobeNewswire - Thu Apr 02, 7:00AM CDT
BioCorRx, Inc. (BICX), developer of the Start Fresh Program(R) used for the treatment of alcohol and opioid dependence, announces its 2014 Financial Results with highlights as follows:
Small Cap IR Correction -- BioCorRx Inc. Positions Itself Through Strategic Partnerships To Gain Market Share Of The $22 Billion Substance Abuse Treatment Market In The U.S.
PR Newswire - Fri Mar 27, 5:23PM CDT
BioCorRx, Inc. (BICX) operating in Santa Ana, California is a healthcare solutions organization, which focuses solely on addiction treatment; the market for which is estimated at $22 billion in the U.S. alone. The Company created a unique treatment program which includes the use of FDA-approved Naltrexone in a specially compounded form for outpatient surgical implantation. The Company has exclusive rights (excluding Australia and New Zealand) to the specially formulated Naltrexone implant. The treatment program also includes an outpatient coaching regimen in which patients receive psycho-social therapy and support for their alcohol or substance abuse addictions.
/DISREGARD RELEASE: Small Cap IR/
PR Newswire - Fri Mar 27, 10:12AM CDT
We are advised by Small Cap IR that journalists and other readers should disregard the news release, BioCorRX Inc. Positions Itself Through New Acquisitions, And Strategic Partnerships To Gain Market Share Of The $22 Billion Substance Abuse Treatment Market In The U.S.: Analyst Report Issued by Small Cap IR, issued 27-Mar-2015 over PR Newswire. A corrected release will be issed later today.
BioCorRX Inc. Positions Itself Through New Acquisitions, And Strategic Partnerships To Gain Market Share Of The $22 Billion Substance Abuse Treatment Market In The U.S.: Analyst Report Issued by Small Cap IR
PR Newswire - Fri Mar 27, 6:00AM CDT
BioCorRx, Inc. (OTCBB: BICX) operating in Santa Ana, California is a healthcare solutions organization, which focuses solely on addiction treatment; the market for which is estimated at $22 billion in the U.S. alone. The Company utilizes a unique treatment regiment through the use of FDA-approved Naltrexone, which the Company has exclusive rights to (excluding Australia and New Zealand). This program is also supplemented with heavy life coaching in which patients receive further treatment for their alcohol or substance abuse addictions.
Brady Granier, Chief Operating Officer and Interim Chief Executive Officer of BioCorRx, Inc., Discusses Recent News in a New Audio Interview at SmallCapVoice.com
GlobeNewswire - Thu Mar 26, 7:00AM CDT
SmallCapVoice.com, Inc. (SCV) announced today that a new audio interview with BioCorRx, Inc. (OTC QB:BICX), developer of the Start Fresh Program, is now available. The interview can be heard at http://smallcapvoice.com/blog/3-24-15-smallca...x-inc-bicx.
BioCorRx, Inc. Announces New Agreements With Wellness Centers in Slidell, LA, Memphis and Nashville, TN, and Philadelphia, PA
Marketwired - Thu Jan 14, 9:06AM CST
BioCorRx, Inc. (OTCQB: BICX), developer of the BioCorRx(R) Recovery Program, a non-addictive Medication-Assisted Treatment (MAT) program used in the treatment of alcohol and opioid addiction, announces new distribution agreements with existing wellness centers. The agreements are part of the company's continued focus to distribute its addiction treatment program, built around long-lasting Naltrexone therapy, to independent locations nationally. The new centers are to be located in Slidell, LA, Memphis, TN, Nashville, TN, and Philadelphia, PA. Visit www.BeatAddiction.com for the most up to date list of locations treating patients currently or for those coming soon.
BioCorRx, Inc. Announces Agreements With Additional Wellness Centers in California, Wisconsin and Arizona; Recent Appearance on National Television
Marketwired - Mon Dec 07, 2:30PM CST
BioCorRx, Inc. (OTCQB: BICX), developer of the BioCorRx(R) Recovery Program, a Medication-Assisted Treatment (MAT) program used in the treatment of alcohol and opioid addiction, announces new distribution agreements with existing wellness centers. The agreements are part of the company's continued focus to distribute its addiction treatment program, built around long-lasting Naltrexone therapy, to wellness centers nationally. The new centers are to be located in Oxnard, CA, Oconomowoc, WI, and Mesa, AZ. In addition to these recent agreements, many of the centers in other areas previously disclosed are now treating patients. Visit www.BeatAddiction.com for the most up to date list of locations treating patients currently or for those coming soon.
BioCorRx, Inc. Secures Tactical Growth Partners as Strategic Advisors; Announces New Branding Strategy
Marketwired - Wed Nov 18, 6:00AM CST
BioCorRx, Inc. (OTCQB: BICX), developer of the BioCorRx(R) Recovery Program, a Medication-Assisted Treatment (MAT) program, announced today they have entered into an agreement to engage the global business and capital markets advisory firm, Tactical Growth Partners "TGP". The principals of TGP have over seventy-five years of Wall Street experience within the small-cap, emerging growth global market as well as in the fields of medicine, medical technology and business development. TGP will provide assistance with strategic planning and business development, general advisory services, communications to the financial community and other services as agreed to.
BioCorRx, Inc. Announces Agreement with Wellness Center in Atlanta Area; Recent Company Interviews
GlobeNewswire - Thu Oct 08, 7:00AM CDT
BioCorRx, Inc. (OTCQB:BICX), developer of the BioCorRx(R) Recovery Program, a Medication-Assisted Treatment (MAT) program, announces a new distribution agreement with an existing wellness center in the Atlanta area. The agreement is part of the Company's continued focus to distribute its addiction treatment program specific to long-lasting Naltrexone therapy to wellness centers nationally through a partnership with Myriad Medical Marketing (MMM). The new center, Superior Health Care LLC, is run by Dr. Steve Peyroux and is located at 2050 Cumming Way, #100 Canton, GA 30115.
BioCorRx, Inc. Announces New Program and Outlines Growth Strategy in Special Letter to Shareholders
GlobeNewswire - Thu Sep 17, 7:00AM CDT
Dear Fellow Shareholder,
BioCorRx, Inc. Announces Start Fresh Program(r) Agreement with Two Additional Wellness Centers
GlobeNewswire - Thu Sep 03, 7:00AM CDT
BioCorRx, Inc. (BICX), developer of the Start Fresh Program, a Medication-Assisted Treatment (MAT) program, announces distribution agreements to bring the Start Fresh Program into two additional wellness centers. The agreement is part of the company's continued focus to distribute its addiction treatment program to wellness centers nationally through a partnership with Myriad Medical Marketing (MMM). The new centers are Escalon Physical Medicine and Scott Medical Health Center PC. "The upcoming availability of our program at two new centers is exciting as they will be continuing our mission of greater accessibility of the Start Fresh Program throughout the country," stated COO & interim CEO, Brady Granier.
SeeThruEquity Initiates Coverage on BioCorRx Inc. with a Price Target of $0.13
ACCESSWIRE - Wed Jul 22, 8:01AM CDT
NEW YORK, NY / ACCESSWIRE / July 22, 2015 / SeeThruEquity, a leading independent equity research and corporate access firm focused on smallcap and microcap public companies, today announced it has initiated coverage of BioCorRx Inc. (OTCQB: BICX) with a Price Target of $0.13.
BioCorRx, Inc. Chief Financial Officer, Lourdes Felix and Brady Granier, Chief Operating Officer and Interim Chief Executive Officer, Discuss Recent News in a New Audio Interview at SmallCapVoice.com
GlobeNewswire - Mon Jul 20, 7:00AM CDT
SmallCapVoice.com, Inc. (SCV) and BioCorRx, Inc. (OTCQB:BICX) developer of the Start Fresh Program (R) used for the treatment of alcohol and opioid dependence, announced today that a new audio interview is now available. The interview can be heard at http://smallcapvoice.com/blog/7-16-15-smallca...x-inc-bicx
BioCorRx, Inc. Finalizes Asset Purchase Agreement to Acquire Naltrexone Implant Formula for Treating Addiction
GlobeNewswire - Tue Jul 07, 7:00AM CDT
BioCorRx, Inc. (BICX), developer of the Start Fresh Program(R) used for the treatment of alcohol and opioid dependence, announces the finalization of an asset purchase agreement with Trinity Compound Solutions (formerly Trinity Rx Solutions) ("Trinity"
for its Naltrexone implant formula with an option to purchase other formulas from Trinity. The Company had previously entered into a letter of understanding (LOU) with Trinity for this agreement. This naltrexone pellet formula is used by a select compounding pharmacist trained to make the specific implant used in the Start Fresh Program. The Company currently has exclusive use rights to the implant in the U.S. and abroad (excluding Australia and New Zealand). BioCorRx, Inc. Announces First Patients Treated in Wellness Center Pilot Using the Start Fresh Program
GlobeNewswire - Mon Jul 06, 7:00AM CDT
BioCorRx, Inc. (BICX), developer of the Start Fresh Program, announces update on the Company's pilot program with Myriad Medical Marketing (MMM). The first location in the pilot program, Corona Physical Medicine (CPM), has just treated their first three patients using the Start Fresh Program. CPM is located at 1150 El Camino Avenue, Suite 108, Corona, CA 92879.
BioCorRx, Inc. and Sobriety and Addiction Solutions, LLC Announce Mutual Separation; Plan to Advocate for Wider Naltrexone Implant Use in the Treatment of Addiction
GlobeNewswire - Thu Jul 02, 1:55PM CDT
BioCorRx, Inc. (BICX), developer of the Start Fresh Program, announces the mutual release of Sobriety and Addiction Solutions, LLC (SAS) from its license agreements with the Company. They were previously offering the Start Fresh Program for locations in Walnut Creek, Fresno and Washington D.C. under MyLife Recovery Centers (MyLife). With different views on how to best approach and capture market share of the $35 billion addiction treatment industry, the companies felt that this separation would allow each party to pursue their respective strategies to help more people suffering from addiction in the largely fragmented addiction treatment market.
BUYINS.NET Updates BioCorRx (BICX) SqueezeTrigger Report
M2 - Wed Jun 10, 8:56AM CDT
BUYINS.NET, http://www.buyins.net, a leading provider of Regulation SHO compliance monitoring, short sale trading statistics and market integrity surveillance, has updated coverage on BioCorRx (OTC: BICX) after releasing the latest short sale data through June 9, 2015. The total aggregate number of shares shorted since August 2010 is approximately 55.6 million shares. Approximately 24.95% of daily trading volume is short selling. The SqueezeTrigger price for all BICX shares shorted is $0.22. A short squeeze is expected to begin when shares of BICX close above the $0.22 SqueezeTrigger price.
BioCorRx Inc. Reports First Quarter 2015 Financial Results
GlobeNewswire - Wed May 20, 2:08PM CDT
BioCorRx Inc. Reports First Quarter 2015 Financial Results
BioCorRx, Inc. and Start Fresh Featured on MSNBC, SAMHSA and NIAAA Endorse Medication for Treatment of Alcohol Abuse Disorders
GlobeNewswire - Tue Apr 28, 7:00AM CDT
BioCorRx, Inc. (BICX) announces MSNBC segment featuring Brady Granier, COO and interim CEO, alongside Start Fresh Program and Growing Pains alum, Jeremy Miller. The two were interviewed by Tamron Hall of NewsNation to discuss Jeremy's success with the Start Fresh Program, a medication-assisted treatment program developed by BioCorRx that is used to treat alcohol and opioid addiction. The MSNBC segment originally aired on April 21, 2015 and can be viewed online here.
BioCorRx, Inc. Announces Start Date of Start Fresh Program(r) Pilot at Wellness Center in Corona, CA
GlobeNewswire - Tue Apr 14, 7:00AM CDT
BioCorRx, Inc. (BICX), developer of the Start Fresh Program, announces that the Company's pilot program that was created as a result of an agreement with Myriad Medical Marketing (MMM) is scheduled to launch later this month. As of April 27, 2015 Corona Physical Medicine (CPM) in Corona, CA plans to begin setting appointments with potential patients. CPM is located at 1150 El Camino Avenue, Suite 108, Corona, CA 92879. This will be the first of five planned locations to participate in the Start Fresh pilot program. Upon successful completion of the pilot program, MMM will begin to introduce the Start Fresh Program to other wellness centers nationwide.
BioCorRx, Inc. Reports 2014 Financial Results
GlobeNewswire - Thu Apr 02, 7:00AM CDT
BioCorRx, Inc. (BICX), developer of the Start Fresh Program(R) used for the treatment of alcohol and opioid dependence, announces its 2014 Financial Results with highlights as follows:
Small Cap IR Correction -- BioCorRx Inc. Positions Itself Through Strategic Partnerships To Gain Market Share Of The $22 Billion Substance Abuse Treatment Market In The U.S.
PR Newswire - Fri Mar 27, 5:23PM CDT
BioCorRx, Inc. (BICX) operating in Santa Ana, California is a healthcare solutions organization, which focuses solely on addiction treatment; the market for which is estimated at $22 billion in the U.S. alone. The Company created a unique treatment program which includes the use of FDA-approved Naltrexone in a specially compounded form for outpatient surgical implantation. The Company has exclusive rights (excluding Australia and New Zealand) to the specially formulated Naltrexone implant. The treatment program also includes an outpatient coaching regimen in which patients receive psycho-social therapy and support for their alcohol or substance abuse addictions.
/DISREGARD RELEASE: Small Cap IR/
PR Newswire - Fri Mar 27, 10:12AM CDT
We are advised by Small Cap IR that journalists and other readers should disregard the news release, BioCorRX Inc. Positions Itself Through New Acquisitions, And Strategic Partnerships To Gain Market Share Of The $22 Billion Substance Abuse Treatment Market In The U.S.: Analyst Report Issued by Small Cap IR, issued 27-Mar-2015 over PR Newswire. A corrected release will be issed later today.
BioCorRX Inc. Positions Itself Through New Acquisitions, And Strategic Partnerships To Gain Market Share Of The $22 Billion Substance Abuse Treatment Market In The U.S.: Analyst Report Issued by Small Cap IR
PR Newswire - Fri Mar 27, 6:00AM CDT
BioCorRx, Inc. (OTCBB: BICX) operating in Santa Ana, California is a healthcare solutions organization, which focuses solely on addiction treatment; the market for which is estimated at $22 billion in the U.S. alone. The Company utilizes a unique treatment regiment through the use of FDA-approved Naltrexone, which the Company has exclusive rights to (excluding Australia and New Zealand). This program is also supplemented with heavy life coaching in which patients receive further treatment for their alcohol or substance abuse addictions.
Brady Granier, Chief Operating Officer and Interim Chief Executive Officer of BioCorRx, Inc., Discusses Recent News in a New Audio Interview at SmallCapVoice.com
GlobeNewswire - Thu Mar 26, 7:00AM CDT
SmallCapVoice.com, Inc. (SCV) announced today that a new audio interview with BioCorRx, Inc. (OTC QB:BICX), developer of the Start Fresh Program, is now available. The interview can be heard at http://smallcapvoice.com/blog/3-24-15-smallca...x-inc-bicx.
